Scientists at the University of Florida created a personalized mRNA vaccine that, in early human trials, rapidly reprogrammed patients’ immune systems to attack glioblastoma within 48 hours; tested on four individuals and inspired by COVID-19 vaccine technology, it bypasses chemotherapy and radiation, shows promise as a potential universal cancer treatment, and has sparked both hope and skepticism as trials expand, including to children.